The State of Security Data Management 2022

whitePaper | September 1, 2022

Artificial Intelligence (AI) is not a recently discovered field. Since the beginning of the computer science discipline, in the late 1950s, AI has drawn a lot of attention in the international scientific community and since then it has represented a field of study which has triggered diverse and numerous research activities.

whitePaper | January 18, 2023

Ventana Research performed this research and analysis independently. Our goals were to determine the Value Index for Data Platforms and to evaluate vendors and products in accordance with the Ventana Research methodology and blueprint. We charged no fees for this research and invited to participate all vendors that are delivering relevant data platform products and services. This report includes products generally available as of September 30, 2022.

whitePaper | September 6, 2022

Data is the heartbeat of the modern enterprise. Technology has progressed to the point that data-driven decision making is the norm and data literacy is often prized above all other skills.

whitePaper | June 23, 2021

Analytical data infrastructure (ADI) platforms underpin key analytics models via processes like data integration, preparation, management, and storage. But with complex cloud architectures, as-a-service offerings, and innovative new analytics and process developments, how can the discerning expert choose the right ADI offerings for their business?

whitePaper | September 1, 2022

Lock-in occurs when the cost or effort of moving away from a particular choice (platform, vendor) outweighs the benefit of doing so, even if that choice is good for the business overall. The pain of moving is simply too great to consider doing it.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.